2016 European guideline on Mycoplasma genitalium infections

Journal of the European Academy of Dermatology and Venereology

Volumn 30, Issue 10, 2016, Pages 1650-1656

  Jensen, J S ^a   Cusini, M ^b   Gomberg, M ^c   Moi, H ^d  

^a STATENS SERUM INSTITUT   (Denmark)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology   (Russian Federation)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; JOSAMYCIN; MACROLIDE; MOXIFLOXACIN; PRISTINAMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ANTIBIOTIC RESISTANCE; ASYMPTOMATIC INFECTION; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DRUG DOSE REDUCTION; DYSPAREUNIA; DYSURIA; EPIDIDYMITIS; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INFECTION RISK; MYCOPLASMA GENITALIUM; MYCOPLASMOSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PATIENT CARE; PATIENT EDUCATION; PELVIC INFLAMMATORY DISEASE; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; SEXUAL BEHAVIOR; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME; UNPROTECTED SEX; URETHRAL DISCHARGE; URETHRITIS; UTERINE CERVICITIS; VAGINA DISCHARGE; COMPLICATION; EUROPE; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MYCOPLASMA INFECTIONS; PATHOPHYSIOLOGY;

ANTI-BACTERIAL AGENTS; EUROPE; FEMALE; HUMANS; MACROLIDES; MALE; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS;

EID: 84991699153     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13849     Document Type: Review

References (63)

1. Taylor-Robinson D, Gilroy CB, Jensen JS. The biology of Mycoplasma genitalium. Venereology 2000; 13: 119–127.
2. Tully JG, Taylor-Robinson D, Cole RM, Rose DL. A newly discovered mycoplasma in the human urogenital tract. Lancet 1981; 1: 1288–1291.
3. Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly. Clin Microbiol Rev 2011; 24: 498–514.
4. Andersen B, Sokolowski I, Østergaard L et al. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Transm Infect 2007; 83: 237–241.
5. Oakeshott P, Aghaizu A, Hay P et al. Is Mycoplasma genitalium in women the “New Chlamydia?” A community-based prospective cohort study. Clin Infect Dis 2010; 51: 1160–1166.
6. Manhart LE, Holmes KK, Hughes JP, Houston LS, Totten PA. Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am J Public Health 2007; 97: 1118–1125.
7. Sonnenberg P, Ison CA, Clifton S et al. Epidemiology of Mycoplasma genitalium in British men and women aged 16-44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Int J Epidemiol 2015; 44: 1982–1994.
8. Cohen CR, Manhart LE, Bukusi EA et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765–766.
9. Manhart LE, Critchlow CW, Holmes KK et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 2003; 187: 650–657.
10. Cohen CR, Mugo NR, Astete SG et al. Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect 2005; 81: 463–466.
11. Anagrius C, Loré B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 2005; 81: 458–462.
12. Falk L, Fredlund H, Jensen JS. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect 2005; 81: 73–78.
13. Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis 2015; 61: 418–426.
14. Oakeshott P, Hay P, Taylor-Robinson D et al. Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome. BJOG 2004; 111: 1464–1467.
15. Peuchant O, Le RC, Desveaux C et al. Screening for Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium should it be integrated into routine pregnancy care in French young pregnant women? Diagn Microbiol Infect Dis 2015; 82: 14–19.
16. Wikström A, Jensen JS. Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline. Sex Transm Infect 2006; 82: 276–279.
17. Jensen JS, Bradshaw C. Management of Mycoplasma genitalium infections - can we hit a moving target? BMC Infect Dis 2015; 15: 343.
18. Vandepitte J, Weiss HA, Bukenya J et al. Association between Mycoplasma genitalium infection and HIV acquisition among female sex workers in Uganda: evidence from a nested case-control study. Sex Transm Infect 2014; 90: 545–549.
19. Mavedzenge SN, Van der Pol B, Weiss HA et al. The association between Mycoplasma genitalium and HIV-1 acquisition among women in Zimbabwe and Uganda. AIDS 2012; 26: 617–624.
20. Manhart LE. Another STI associated with HIV-1 acquisition: now what? AIDS 2012; 26: 635–637.
21. Soni S, Alexander S, Verlander N et al. The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic. Sex Transm Infect 2010; 86: 21–24.
22. Lillis RA, Nsuami MJ, Myers L, Martin DH. Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women. J Clin Microbiol 2011; 49: 1990–1992.
23. Edlund M, Blaxhult A, Bratt G. The spread of Mycoplasma genitalium among men who have sex with men. Int J STD AIDS 2012; 23: 455–456.
24. Bradshaw CS, Fairley CK, Lister NA et al. Mycoplasma genitalium in men who have sex with men at male-only saunas. Sex Transm Infect 2009; 85: 432–435.
25. Deguchi T, Yasuda M, Yokoi S et al. Failure to detect Mycoplasma genitalium in the pharynges of female sex workers in Japan. J Infect Chemother 2009; 15: 410–413.
26. Luki N, Lebel P, Boucher M et al. Comparison of polymerase chain reaction assay with culture for detection of genital mycoplasmas in perinatal infections. Eur J Clin Microbiol Infect Dis 1998; 17: 255–263.
27. Walker J, Fairley CK, Bradshaw CS et al. The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women. BMC Infect Dis 2011; 11: 35.
28. Jensen JS, Björnelius E, Dohn B, Lidbrink P. Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic. Sex Transm Dis 2004; 31: 499–507.
29. Salado-Rasmussen K, Jensen JS. Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. Clin Infect Dis 2014; 59: 24–30.
30. Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. Am J Obstet Gynecol 2012; 206: 476–478.
31. Taylor-Robinson D, Gilroy CB, Horowitz S, Horowitz J. Mycoplasma genitalium in the joints of two patients with arthritis. Eur J Clin Microbiol Infect Dis 1994; 13: 1066–1069.
32. Falk L, Fredlund H, Jensen JS. Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis. Sex Transm Infect 2004; 80: 289–293.
33. Horner PJ, Taylor-Robinson D. Association of Mycoplasma genitalium with balanoposthitis in men with non-gonococcal urethritis. Sex Transm Infect 2011; 87: 38–40.
34. Björnelius E, Jensen JS, Lidbrink P. Conjunctivitis Associated with Mycoplasma genitalium Infection. Clin Infect Dis 2004; 39: e67–e69.
35. Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008; 47: 1546–1553.
36. Twin J, Jensen JS, Bradshaw CS et al. Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis. PLoS ONE 2012; 7: e35593.
37. Jensen JS. Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistance-mediating mutations in region V of the 23S rRNA gene. In MacKenzie CR, Henrich B, eds. Diagnosis of Sexually Transmitted Diseases; Methods and Protocols, 903 edn. Humana Press, Springer, New York, 2012: 129–139.
38. Touati A, Peuchant O, Jensen JS, Bebear C, Pereyre S. Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis. J Clin Microbiol 2014; 52: 1549–1555.
39. Wold C, Sorthe J, Hartgill U et al. Identification of macrolide-resistant Mycoplasma genitalium using real-time PCR. J Eur Acad Dermatol Venereol 2015; 29: 1616–1620.
40. Pond MJ, Nori AV, Witney AA et al. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. Clin Infect Dis 2014; 58: 631–637.
41. Shimada Y, Deguchi T, Nakane K et al. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance. Int J Antimicrob Agents 2010; 36: 255–258.
42. Couldwell DL, Tagg KA, Jeoffreys NJ, Gilbert GL. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD AIDS 2013; 24: 822–828.
43. Kikuchi M, Ito S, Yasuda M et al. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. J Antimicrob Chemother 2014; 69: 2376–2382.
44. Hardick J, Giles J, Hardick A et al. Performance of the Gen-Probe transcription-mediated amplification research assay compared to that of a multitarget real-time PCR for Mycoplasma genitalium detection. J Clin Microbiol 2006; 44: 1236–1240.
45. Wroblewski JK, Manhart LE, Dickey KA, Hudspeth MK, Totten PA. Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium. J Clin Microbiol 2006; 44: 3306–3312.
46. Carlsen KH, Jensen JS. Mycoplasma genitalium PCR: does freezing of specimens affect sensitivity? J Clin Microbiol 2010; 48: 3624–3627.
47. Reinton N, Moi H, Olsen AO et al. Anatomic distribution of Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium infections in men who have sex with men. Sex Health 2013; 10: 199–203.
48. Björnelius E, Anagrius C, Bojs G et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect 2008; 84: 72–76.
49. Mena LA, Mroczkowski TF, Nsuami M, Martin DH. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 2009; 48: 1649–1654.
50. Schwebke JR, Rompalo A, Taylor S et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens - A Randomized Clinical Trial. Clin Infect Dis 2011; 52: 163–170.
51. Manhart LE, Gillespie CW, Lowens MS et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis 2013; 56: 934–942.
52. Nijhuis RH, Severs TT, Van der Vegt DS, Van Zwet AA, Kusters JG. High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment. J Antimicrob Chemother 2015; 70: 2515–2518.
53. Bradshaw CS, Jensen JS, Tabrizi SN et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12: 1149–1152.
54. Jernberg E, Moghaddam A, Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008; 19: 676–679.
55. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS ONE 2008; 3: e3618.
56. Anagrius C, Lore B, Jensen JS. Treatment of Mycoplasma genitalium. Observations from a Swedish STD Clinic. PLoS ONE 2013; 8: e61481.
57. Terada M, Izumi K, Ohki E, Yamagishi Y, Mikamo H. Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium. J Infect Chemother 2012; 18: 313–317.
58. Gundevia Z, Foster R, Jamil MS, McNulty A. Positivity at test of cure following first-line treatment for genital Mycoplasma genitalium: follow-up of a clinical cohort. Sex Transm Infect 2015; 91: 11–13.
59. Bissessor M, Tabrizi SN, Twin J et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis 2015; 60: 1228–1236.
60. Judlin P, Liao Q, Liu Z et al. Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study. BJOG 2010; 117: 1475–1484.
61. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64 (RR-03): 1–137.
62. Horner P, Blee K, O'Mahony C et al. 2015 UK National Guideline on the management of non-gonococcal urethritis. Int J STD AIDS 2016; 27: 85–96.
63. Falk L, Enger M, Jensen JS. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women. J Antimicrob Chemother 2015; 70: 3134–3140.